‘Seizing a disruptive opportunity’ to improve gender equity in medicine
The pandemic has magnified issues of gender equity that permeate medicine. Can it also be the catalyst for real change?
June 14, 2021 5:00 AM
Nicole Fawcett
Director of Communications, University of Michigan Rogel Cancer
Fawcett leads a team of communicators who produce targeted, innovative communication for the Rogel Cancer Center’s research and clinical enterprises. Prior to Michigan Medicine, Fawcett was a reporter at the Detroit News and editor for a web-based community for people with disabilities.
Analysis Reveals How Kidney Cancer Develops and Responds to Treatment
Findings offer clues to why some types of renal cell carcinoma respond to immunotherapy while others do not.
June 04, 2021 2:53 PM
Study Suggests Path to Blocking Common Genetic Driver of Lung Cancer
Stopping the interaction between KRAS and the protein AGO2 slowed tumor growth in mouse models.
May 10, 2021 3:00 PM
HPV Fuels Uptick in Head and Neck Cancers in Taiwan, Study Finds
Vaccines and other policies could help keep in check a disease that’s becoming increasingly common worldwide.
April 25, 2021 2:25 PM
How a Little-Known Glycoprotein Blocks a Cancer Cell’s Immune Response
Targeting this inside-the-cell checkpoint could potentially improve response to cancer immunotherapy.
January 28, 2021 11:00 AM
Study Explains Why Patients with Cancer Spread to the Liver Have Worse Outcomes
The liver siphons critical immune cells to render immunotherapy ineffective; radiation to the liver may block this process.
January 04, 2021 9:31 AM
More Authors
Kara Gavin
Research and Policy Media Relations Manager
